{
    "nctId": "NCT02869815",
    "briefTitle": "ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant Therapy",
    "officialTitle": "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Using the Navigation of the Combination of Indocyanine and Blue Dye in Patients With Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Detection rate of SLN",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients indicated for neoadjuvant therapy\n* Have complete evaluation of the axillary status\n* Planned for axillary clearance after neoadjuvant therapy\n\nExclusion Criteria:\n\n* Sensitive to Iodine\n* Inflammatory disease\n* Patient's refusal to join the trial",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}